Thus, our in vitro data provides evidence that, in GC cells expressing E-cadherin, silencing of S100P affects E-cadherin expression and function, induces apoptosis resistance and awards cells with increased invasive abilities. The gene discussed is S100P; the disease is gastric cancer.